Sanofi logs six trial updates: new Nuvaxovid, frexalimab, colitis studies and Fabry data lockNov 13Weekly roundup, 10 itemsfexofenadinefrexalimabUpdated
Scribe Therapeutics advances STX-1150 Phase 1 trial, expands Sanofi dealNov 12Quarterly updateSanofiScribe Therapeutics, Inc.
Teva's anastrozole label supplement approved; Sanofi duvakitug HS trial still recruitingNov 9Weekly roundup, 2 itemsanastrozoleduvakitug
Teva completes Phase 3 asthma inhaler trial; registers vitiligo program and five ANDA actionsNov 6Weekly roundup, 8 itemsalbuterolduvakitug
Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride
Regeneron-linked TOP2201 posts results; NeoSTOP-IT terminated, DEUTERON completedNov 5Weekly roundup, 7 itemsafliberceptALN-CIDEBUpdated
Sanofi ends Phase 1 trial of STAT6 degrader partnered with NurixNov 3Clinical readoutNurix Therapeutics, Inc.Sanofi
Sanofi's Phase 2 atopic dermatitis trial of SAR444656 ends early, results postedNov 3Trial updateKymera Therapeutics, Inc.Sanofi
Recursion reports Phase 2 FAP data, Sanofi option, Hassan as new chairNov 2Quarterly updateREC-1245Recursion Pharmaceuticals, Inc.
Regeneron registers Phase 3 LINKER-AL1 trial of linvoseltamab for AL amyloidosisOct 30Weekly roundup, 6 itemscemiplimab-rwlcdupilumabUpdated
Sanofi registers three-country OPTIMUS RISK cardiovascular cohort studies in ASCVD patientsOct 30Weekly roundup, 6 itemsfitusiranlunsekimigUpdated
Novavax earns $125 million as Sanofi dosing triggers flu-COVID vaccine trial milestoneOct 29Clinical readoutNovavaxSanofi
Sanofi's NKCE trial SAR443579 in AML halted early; results posted for terminated studyOct 23Weekly roundup, 6 itemsBayerdiclofenac
Sanofi terminates Phase 2 SPECIFI-UC trial of SAR441566 in ulcerative colitisOct 22Trial updatebalinatunfibSanofi
Regeneron week: AERIFY-1 COPD results posted; new cenvacibart, alirocumab, cemiplimab trials filedOct 16Weekly roundup, 6 itemsalirocumabcemiplimab-rwlcUpdated
Recursion prices $200M offering, reports Sanofi milestone and TUPELO, DAHLIA dataOct 15Quarterly updateAlector, Inc.REC-1245Updated
Sanofi registers new RSV immunization survey; three prior Queensland studies also updateOct 15Weekly roundup, 7 itemsSanofiUpdated
Regeneron registers Phase 1b hemodialysis study, Phase 1 Graves' disease trialOct 9Weekly roundup, 6 itemsamrecibartbortezomib